L

Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.

13 employees

Livzon Mabpharm is a Chinese biotechnology company focused on the development, manufacture, and sale of antibody-based drugs.

Investor insights

Sectors invested in

Therapeutics1
Biotechnology1
Life Science1

Funding rounds participated in

$36M sweet spot round size

Most of their 1 investments are in rounds between $36M and $36M

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Health Care

Date founded

2010

Investments made

E

EPIRUS Biopharmaceuticals raised $36M on April 16, 2014

Investors: Mousse Partners, 5AM Ventures, Montreux Equity Partners, Gibralt Capital Corporation, Adage Capital Management and Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.

Funding rounds raised

L

Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. raised undisclosed on June 27, 2018

Investors: Livzon

FAQ